hiv risk behaviors
Recently Published Documents


TOTAL DOCUMENTS

467
(FIVE YEARS 35)

H-INDEX

51
(FIVE YEARS 2)

2021 ◽  
Vol 3 ◽  
Author(s):  
Edward Nyaboe ◽  
Anna Larsen ◽  
Joseph Sila ◽  
John Kinuthia ◽  
George Owiti ◽  
...  

Background: Understanding HIV risk behaviors among adolescent girls and young women (AGYW) seeking contraception could help inform integrating HIV prevention services within family planning (FP) clinics.Methods: From 10/2018 to 04/2019, we conducted a survey at 4 FP clinics in Kisumu, Kenya to evaluate risk behaviors among AGYW without HIV infection seeking contraception. All AGYW aged 15–24 were invited to participate following receipt of FP services. Adolescent girls and young women initiating or refilling contraception were included in this analysis. Long-acting reversible contraceptives (LARC) included intrauterine devices, implants, or injectables. Non-LARC methods included oral contraceptive pills (OCP) or condoms. We used an empiric risk score to assess HIV risk behaviors; HIV risk scores of ≥5 (corresponding to 5–15% HIV incidence) defined “high” HIV risk.Results: Overall, 555 AGYW seeking FP were included. Median age was 22 years [interquartile range (IQR) 20–23], median completed education was 12 years (IQR 10–12); 23% of AGYW had HIV risk scores of ≥5. The most frequent form of contraception was injectables (43%), followed by implants (39%). After adjustment for education, prior pregnancy, and marital status, LARC users more frequently engaged in transactional sex than non-LARC users [6 vs. 0%, adjusted prevalence ratio (PR) = 1.17, 95% CI 1.09–1.29, p < 0.001]; LARC use was not associated with HIV risk scores ≥5. Among LARC users, AGYW using injectables more frequently had condomless sex compared to AGYW using other LARC methods (85 vs. 75%, adjusted PR = 1.52, 95% CI 1.09–2.10, p = 0.012); injectable use was not associated with HIV risk scores ≥5.Conclusions: Adolescent girls and young women seeking contraception frequently had high HIV risk, emphasizing the importance of integrating HIV prevention within FP. Multipurpose technologies for contraception and HIV prevention could particularly benefit AGYW.


Author(s):  
Brittany Wilbourn ◽  
Brittani Saafir-Callaway ◽  
Kamwing Jair ◽  
Joel O Wertheim ◽  
Oliver Laeyendecker ◽  
...  

Author(s):  
Ariel Ludwig ◽  
Laura B. Monico ◽  
Jan Gryczynski ◽  
Elizabeth Lertch ◽  
Robert Schwartz ◽  
...  

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Joseph B. Nguemo Djiometio ◽  
Asfaw Buzuayew ◽  
Hodan Mohamud ◽  
Irene Njoroge ◽  
Meldon Kahan ◽  
...  

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
P. F. Blatyta ◽  
◽  
S. Kelly ◽  
T. T. Goncalez ◽  
A. B. Carneiro-Proietti ◽  
...  

Abstract Background A low prevalence of HIV in sickle cell disease (SCD) patients has been reported in the literature though mechanisms for this are not understood. Methods HIV risk behaviors were compared between SCD cases and non-SCD controls using a self-administered audio computer-assisted self-interview. SCD cases were recruited from a multi-center SCD cohort established in Brazil; controls were recruited from SCD social contacts. Categorical variables were analyzed using Chi-Square or Fisher exact test. Continuous variables were compared using the Mann-Whitney U test. Results There were 152 SCD cases and 154 age/location matched controls enrolled at three participating Brazilian centers during 2016–17. No significant differences in number of sexual partners (lifetime or previous 12 months), male-to-male sex partners or intravenous drug use were observed. Cases received more transfusions, surgeries, and acupuncture treatment. Conclusions Besides the risk of transfusion-transmitted HIV, which is now exceedingly rare, SCD and non-SCD participants demonstrated similar HIV risk behaviors. Causes other than risk behaviors such as factors inherent to SCD pathophysiology may explain the reported low prevalence of HIV in SCD.


Sign in / Sign up

Export Citation Format

Share Document